Keros Therapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Sell

KROS
Keros Therapeutics

Last Price:

$16.76

Seasonality Move:

16.43%

7 Day Trial

ALL ACCESS PASS

$ 7

Elon Musk Predicts MAJOR Crisis in Trump's First Year

See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.

Keros Therapeutics Stock Forecast

Over the next 52 weeks, Keros Therapeutics has on average historically fallen by 28.2% based on the past 4 years of stock performance.
Keros Therapeutics has fallen lower in 4 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
Is Keros Therapeutics Stock Undervalued?

The current Keros Therapeutics [KROS] share price is $16.71. The Score for KROS is 10, which is 80% below its historic median score of 50, and infers higher risk than normal.
KROS is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.

Will Keros Therapeutics Stock Go Up Next Year?

Over the next 52 weeks, Keros Therapeutics has on average historically fallen by 28.2% based on the past 4 years of stock performance.

Keros Therapeutics Stock Rating

Sell

Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics overpriced?

Keros Therapeutics has fallen lower in 4 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%

Keros Therapeutics Stock Price History

Is KROS stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

kerostx.com

52-Week Data

52-Week High:

73.00

52-Week Low:

15.67

Prediction Charts

Market Cap:

676.9M

Price in USD:

16.71

Volume:

378.8K

Beta:

1.11

Technical Analysis

SMA50:

53.27

SMA100:

52.76

SMA200:

53.34

52-Wk Change:

-56.27%

Stock Predictions

Is Keros Therapeutics stock public?

Yes, Keros Therapeutics is a publicly traded company.
What is the Keros Therapeutics stock quote today?

The Keros Therapeutics stock price is 16.71 USD today.
How to buy Keros Therapeutics stock online?

You can buy Keros Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Dec-5	67.79	64.61	67.79	63.26
Dec-6	64.50	70.00	70.07	64.46
Dec-9	69.90	67.14	72.37	66.82
Dec-10	67.28	66.31	68.44	65.86
Dec-11	67.76	68.65	69.26	66.48
Dec-12	18.71	18.43	19.34	15.67
Dec-13	18.76	18.83	21.05	17.52
Dec-16	18.25	19.42	19.65	18.08
Dec-17	19.33	18.00	19.40	17.77
Dec-18	18.00	17.13	18.33	16.44
Dec-19	17.08	16.92	17.08	16.31
Dec-20	16.77	17.03	17.64	16.62
Dec-23	16.98	17.12	17.50	16.88
Dec-24	17.12	16.71	17.12	16.63

Keros Therapeutics Earnings

Keros Therapeutics Earnings Report: Per Share Keros Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Keros Therapeutics Forecast Revenue Growth

Keros Therapeutics Stock Analysis: Historical quarterly revenues per share for Keros Therapeutics and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.04 per share, and an increase next year of $0.36 per share.

* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.